Giantsoudi Drosoula, Seco Joao, Eaton Bree R, Simeone F Joseph, Kooy Hanne, Yock Torunn I, Tarbell Nancy J, DeLaney Thomas F, Adams Judith, Paganetti Harald, MacDonald Shannon M
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):37-46. doi: 10.1016/j.ijrobp.2017.01.226. Epub 2017 Feb 1.
At present, proton craniospinal irradiation (CSI) for growing children is delivered to the whole vertebral body (WVB) to avoid asymmetric growth. We aimed to demonstrate the feasibility and potential clinical benefit of delivering vertebral body sparing (VBS) versus WVB CSI with passively scattered (PS) and intensity modulated proton therapy (IMPT) in growing children treated for medulloblastoma.
Five plans were generated for medulloblastoma patients, who had been previously treated with CSI PS proton radiation therapy: (1) single posteroanterior (PA) PS field covering the WVB (PS-PA-WVB); (2) single PA PS field that included only the thecal sac in the target volume (PS-PA-VBS); (3) single PA IMPT field covering the WVB (IMPT-PA-WVB); (4) single PA IMPT field, target volume including thecal sac only (IMPT-PA-VBS); and (5) 2 posterior-oblique (-35°, +35°) IMPT fields, with the target volume including the thecal sac only (IMPT2F-VBS). For all cases, 23.4 Gy (relative biologic effectiveness [RBE]) was prescribed to 95% of the spinal canal. The dose, linear energy transfer, and variable-RBE-weighted dose distributions were calculated for all plans using the tool for particle simulation, version 2, Monte Carlo system.
IMPT VBS techniques efficiently spared the anterior vertebral bodies (AVBs), even when accounting for potential higher variable RBE predicted by linear energy transfer distributions. Assuming an RBE of 1.1, the V10 Gy(RBE) decreased from 100% for the WVB techniques to 59.5% to 76.8% for the cervical, 29.9% to 34.6% for the thoracic, and 20.6% to 25.1% for the lumbar AVBs, and the V20 Gy(RBE) decreased from 99.0% to 17.8% to 20.0% for the cervical, 7.2% to 7.6% for the thoracic, and 4.0% to 4.6% for the lumbar AVBs when IMPT VBS techniques were applied. The corresponding percentages for the PS VBS technique were higher.
Advanced proton techniques can sufficiently reduce the dose to the vertebral body and allow for vertebral column growth for children with central nervous system tumors requiring CSI. This was true even when considering variable RBE values. A clinical trial is planned for VBS to the thoracic and lumbosacral spine in growing children.
目前,对正在生长发育的儿童进行质子全脊髓照射(CSI)时,照射范围覆盖整个椎体(WVB)以避免不对称生长。我们旨在证明,对于接受髓母细胞瘤治疗的正在生长发育的儿童,采用椎体 sparing(VBS)对比WVB CSI,联合被动散射(PS)和调强质子治疗(IMPT)的可行性及潜在临床获益。
为曾接受CSI PS质子放射治疗的髓母细胞瘤患者制定了5种计划:(1)单个前后位(PA)PS射野覆盖WVB(PS - PA - WVB);(2)单个PA PS射野,靶区仅包括硬脊膜囊(PS - PA - VBS);(3)单个PA IMPT射野覆盖WVB(IMPT - PA - WVB);(4)单个PA IMPT射野,靶区仅包括硬脊膜囊(IMPT - PA - VBS);(5)2个后斜位(-35°,+35°)IMPT射野,靶区仅包括硬脊膜囊(IMPT2F - VBS)。对于所有病例,95%的椎管处方剂量为23.4 Gy(相对生物效应[RBE])。使用蒙特卡罗系统粒子模拟工具版本2,计算所有计划的剂量、线能量传递和可变RBE加权剂量分布。
IMPT VBS技术能有效减少椎体前部(AVB)的受照剂量,即使考虑线能量传递分布预测的潜在更高可变RBE。假设RBE为1.1,当应用IMPT VBS技术时,V10 Gy(RBE)从WVB技术的100%降至颈椎AVB的59.5%至76.8%、胸椎AVB的29.9%至34.